AnalystsMatthew CaufieldMatthew Caufield's Stock Forecasts
AnalystsMatthew Caufield
Analyst Ranking
Top 7%
#340 out of 5115 analysts
Average Return
+15.7%
Win Rate
45%73 out of 162
Risk vs Reward
Poor
Good
Matthew Caufield's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Phathom Pharmaceuticals IncPHAT | +449.64% | $2.76 | $15.17 | 2025-05-02 - 2025-11-26 | Buy |
Zenas Biopharma IncZBIO | +393.67% | $8.21 | $40.53 | 2025-03-12 - 2025-11-26 | Buy |
Zenas Biopharma IncZBIO | +362.14% | $8.77 | $40.53 | 2024-12-16 - 2025-11-26 | Buy |
Mineralys Therapeutics IncMLYS | +325.10% | $10.20 | $43.36 | 2025-02-13 - 2025-11-26 | Buy |
Zenas Biopharma IncZBIO | +287.11% | $10.47 | $40.53 | 2025-05-16 - 2025-11-26 | Buy |
Matthew Caufield Analyst Color
Get additional color on Matthew Caufield's coverage of popular stocks
Matthew Caufield's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Adverum Biotechnologies IncADVM | 8 | Hold | $5.00 | +20.19% | Downgrades | 12 days ago |
Kodiak Sciences IncKOD | 7 | Buy | $26.00 | +15.86% | Maintains | 12 days ago |
Immunic IncIMUX | 6 | Buy | $8.00 | +1,041.23% | Maintains | 15 days ago |
Mineralys Therapeutics IncMLYS | 13 | Buy | $56.00 | +29.15% | Maintains | 17 days ago |
Fibrobiologics IncFBLG | 7 | Buy | $5.00 | +1,738.24% | Maintains | 24 days ago |
Phathom Pharmaceuticals IncPHAT | 11 | Buy | $26.00 | +71.39% | Maintains | a month ago |
Akebia Therapeutics IncAKBA | 2 | Buy | $6.00 | +277.36% | Maintains | a month ago |
Tarsus Pharmaceuticals IncTARS | 2 | Buy | $88.00 | +9.32% | Maintains | a month ago |
Zenas Biopharma IncZBIO | 4 | Buy | $30.00 | -25.98% | Reiterates | 2 months ago |
Diamedica Therapeutics IncDMAC | 7 | Buy | $12.00 | +31.58% | Reiterates | 3 months ago |
Lyra Therapeutics IncLYRA | 8 | Hold | $16.00 | +357.14% | Reiterates | 3 months ago |
Lenz Therapeutics IncLENZ | 7 | Buy | $56.00 | +82.29% | Maintains | 4 months ago |
Opus Genetics IncIRD | 13 | Buy | $8.00 | +296.04% | Reiterates | 5 months ago |
Ardelyx IncARDX | 1 | Buy | $10.00 | +68.63% | Assumes | 5 months ago |
Unity Biotechnology IncUNBX | 9 | Hold | $2.00 | +900.00% | Downgrades | 6 months ago |
Optinose IncOPTN | 8 | Hold | $9.00 | -6.25% | Reiterates | 6 months ago |
Aldeyra Therapeutics IncALDX | 13 | Buy | $10.00 | +78.89% | Reiterates | 6 months ago |
Surrozen IncSRZN | 3 | Buy | $32.00 | +94.59% | Reiterates | 7 months ago |
Hillevax IncHLVX | 5 | Hold | $2.00 | -4.31% | Reiterates | 8 months ago |
Opthea LtdOPTEY | 7 | Hold | $2.00 | -41.35% | Downgrades | 8 months ago |
Hyperion Defi IncHYPD | 16 | Hold | $2.00 | -52.83% | Reiterates | 8 months ago |
4d Molecular Therapeutics IncFDMT | 18 | Buy | $36.00 | +227.57% | Reiterates | 9 months ago |
FabrinetFN | 1 | Buy | $28.00 | N/A | Reiterates | 2 years ago |
Iveric Bio IncISEE | 6 | Hold | $40.00 | N/A | Downgrades | 3 years ago |
Oyster Point Pharma IncOYST | 1 | Buy | $20.00 | N/A | Initiates Coverage On | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.